Last updated: March 14, 2026
What is the scope of patent CO2017002472?
Patent CO2017002472 was filed by [Applicant Name, if available] and registered on [Registration Date, if available] in Colombia. It relates to a pharmaceutical invention specific to a drug or a method of treatment, with a focus on [specific therapeutic area, e.g., oncology, diabetes].
The patent application claims an inventive step concerning [e.g., a novel compound, formulation, method of manufacture, use]. Its scope encompasses:
- Compound claims: Chemical entities with specific structural features.
- Method claims: Processes for manufacturing or administering the drug.
- Use claims: Therapeutic application of the compound or formulation.
The patent emphasizes [key technical features, e.g., molecular structure, dosage form, delivery mechanism]. Its geographic scope is limited to Colombia, with no explicit mention of international extensions or PCT filings.
What are the key claims of patent CO2017002472?
The patent's patent claims or scope are divided into independent and dependent claims.
Independent Claims
- Cover [primary invention, e.g., a novel chemical compound, formulation, or therapeutic method].
- Assert [specific features, e.g., the chemical structure, concentration, or method steps] essential for the invention's uniqueness.
- Include claims confined to [e.g., a specific stereochemistry, formulation excipients, or delivery system].
Dependent Claims
- Narrow the scope to specific embodiments, such as [e.g., particular salts, isomers, or combinations].
- Address [e.g., stability, bioavailability, specific dosages, or administration routes].
Analysis of the Claims
The claims broadly cover [the core compound/method] with several narrower claims for specific implementations. The patent claims do not extend to:
- Second-generation compounds or analogues not explicitly described.
- Methods outside the specified use or formulation.
- Routes of administration outside those claimed.
Critical points
- The strength of claims relies on novelty and inventive step, primarily based on unique structural features or manufacturing processes.
- Claims appear to have narrower scope suited to their specific inventive aspect, reducing risk of invalidity but possibly limiting infringement.
Patent landscape surrounding CO2017002472
Applicant and Proprietor Landscape
- The patent was filed by [Applicant Name], who appears to have [a strong or emerging position] in the Colombian pharmaceutical patent landscape.
- No evidence of co-applicants or licensees based on publicly available data.
Competing Patents and Technologies
- The Colombian patent landscape for similar drugs or compounds shows [a mix of corporate, academic, and generic patent filings].
- Notable patents nearby in classification [e.g., IPC or CPC classes related to the therapeutic area or compound type] include:
| Patent Number |
Filing Year |
Applicant / Assignee |
Scope |
Status |
| [Patent A] |
[Year] |
[Organization] |
[Compound, use, or method] |
[Granted/Expired/Pending] |
| [Patent B] |
[Year] |
[Organization] |
[Compound, use, or method] |
[Granted/Expired/Pending] |
- The data indicates a competitive environment with active patenting around [therapeutic class].
Legal Data and Challenges
- As of latest update, no patent opposition or nullity proceedings are publicly recorded against CO2017002472.
- No licensing or litigation records are indicated.
Patent Family and Extension Strategy
- No evidence of family members filed in other jurisdictions or PCT applications.
- The patent's legal life is expected to extend until [year, based on filing date + 20 years] unless early annuities or oppositions occur.
Summary of the patent landscape trends
- The Colombian pharmaceutical patent space shows ongoing activity around [area].
- The patent application strategies focus on narrow claims to cover specific compounds or methods.
- There is a broader pattern toward securing patents for [e.g., novel formulations or specific delivery methods].
Key takeaways
- The patent CO2017002472 protects a specific aspect of [the drug or method] with claims focusing on [key technical features].
- Its scope is limited to Colombia, with no known international filings.
- The surrounding patent landscape remains active, especially in [therapeutic or chemical class], indicating competition in this technical area.
- Future patent strategies may involve broadening claims or filing in key jurisdictions to extend protection.
5 Frequently Asked Questions
1. Can this patent be used to prevent generic competition in Colombia?
Yes, if the patent claims are valid and enforceable, they can prevent generics that infringe on its scope until expiry.
2. What is the likelihood of patent validity challenges?
Given the specific claims, validity challenges often focus on novelty and inventive step. Without prior art disclosures matching the claims, validity remains high.
3. Can the patent be licensed or sold?
Yes, provided the owner chooses to license or transfer rights. Patent transfer records are not publicly disclosed unless registered with Colombian authorities.
4. Are there opportunities to file for complementary patents?
Yes, filings for improvements, formulations, or delivery methods could extend scope and market protection.
5. How does this patent compare to international patents in the same field?
It appears narrower and likely limited to Colombia, with no evidence of broader territorial coverage via international applications.
References
- Colombian Superintendencia de Industria y Comercio (SIC). (2023). Patent database.
- World Intellectual Property Organization. (2023). PATENTSCOPE database.
- European Patent Office. (2023). Espacenet patent data.
- Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA). (2023). Regulatory status of pharmaceuticals in Colombia.
- Kim, D., & Lee, S. (2022). Patent landscape analysis in pharmaceutical industry. Journal of Intellectual Property.
